Long‐term outcomes of patients treated with rituximab as second‐line treatment for adult immune thrombocytopenia – Follow‐up of the RITP study
暂无分享,去创建一个
A. Waage | P. Holme | M. Michel | A. Khelif | W. Ghanima | B. Darné | E. Tjønnfjord | Neila Ben Romdhan